Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 727783
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Slc35b1
Name: solute carrier family 35, member B1
Acc ID: CHEBI:4031
Term: cyclosporin A
Definition: A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Chemical ID: MESH:D016572
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Slc35b1increases expressionISOSLC35B1 (Homo sapiens)6480464CTDCyclosporine results in increased expression of SLC35B1 mRNAPMID:20106945 PMID:21632981 PMID:25562108 PMID:27989131
Slc35b1increases expressionISOSlc35b1 (Mus musculus)6480464CTDCyclosporine results in increased expression of SLC35B1 mRNAPMID:19770486 PMID:25270620
Slc35b1multiple interactionsISOSLC35B1 (Homo sapiens)6480464CTD[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SLC35B1 mRNAPMID:33819548
Go Back to source page   Continue to Ontology report